Pembrolizumab

Peripheral-neuropathy and distress respiratory syndrome: 2 case reports

    Reactions Weekly volume 1838, page429(2021)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    US$ 49.95

    Tax calculation will be finalised during checkout.

    Reference

    1. Metro G, et al. Efficacy of Pembrolizumab Monotherapy in Patients with or without Brain Metastases from Advanced Non-Small Cell Lung Cancer with a PD-L1 Expression ≥50%. Journal of Immunotherapy 43: 299-306, No. 9, Nov 2020. Available from: URL: http://doi.org/10.1097/CJI.0000000000000340

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Pembrolizumab. Reactions Weekly 1838, 429 (2021). https://doi.org/10.1007/s40278-021-89746-x

    Download citation